本页面由Tiger Trade Technology Pte. Ltd.提供服务

Curanex Pharmaceuticals

0.3430
0.0000
成交量:1.47万
成交额:4,961.95
市值:972.09万
市盈率:-1.35
高:0.3430
开:0.3400
低:0.3386
收:0.3430
52周最高:9.18
52周最低:0.2620
股本:2,834.08万
流通股本:909.31万
量比:0.26
换手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-0.2550
每股收益(LYR):-0.1657
净资产收益率:-171.42%
总资产收益率:-99.00%
市净率:1.20
市盈率(LYR):-2.07

数据加载中...

公司资料

公司名字:
Curanex Pharmaceuticals
交易所:
NASDAQ
成立时间:
1996
员工人数:
6
公司地址:
2 Jericho Plaza,Suite 101B,Jericho,New York,United States
邮编:
11753
电话:
传真:
- -
简介:
Curanex Pharmaceuticals Inc最初于2018年6月1日在纽约州注册成立,后来转变为特拉华州公司。Curanex是一家处于发展阶段的制药公司,致力于发现、开发和商业化创新的植物药物,以治疗患有炎症性疾病的患者,并开发可能为自身免疫性疾病、代谢性疾病和病毒感染等各个领域临床需求未得到满足的患者提供潜在益处的疗法。

董事

名称
职位
Jun Liu
Chairman of the Board and Chief Executive Officer and Director and President
Helen Hsu
Independent Director
Huijuan Zhong
Chief Scientific Officer and Director
Xiaohui Hao
Independent Director
Yong Yan
Independent Director

股东

名称
职位
Jun Liu
Chairman of the Board and Chief Executive Officer and Director and President
Liqin Xie
Chief Operating Officer
Wanjun Zhang
Chief Financial Officer and Treasurer
Dian Ying Jing
Secretary
Huijuan Zhong
Chief Scientific Officer and Director
Ning Zhang
Chief Technology Officer